Madrigal Pharmaceuticals Stock Forecast

Buy candidate since Jun 18, 2026 Gain 1.52%

The Madrigal Pharmaceuticals, Inc. stock price gained 0.107% on the last trading day (Tuesday, 23rd Jun 2026), rising from $512.88 to $513.43. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 2.84% from a day low at $507.57 to a day high of $522.00. The price has risen in 8 of the last 10 days and is up by 9.88% over the past 2 weeks. Volume fell on the last day by -23 thousand shares and in total, 254 thousand shares were bought and sold for approximately $130.25 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies the upper part of a wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $524.27 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -4.64% during the next 3 months and, with a 90% probability hold a price between $426.37 and $499.96 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

MDGL Signals & Forecast

Mostly positive signals in the chart today. The Madrigal Pharmaceuticals, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $501.95 and $504.13. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, June 02, 2026, and so far it has risen 13.37%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Support, Risk & Stop-loss for Madrigal Pharmaceuticals, Inc. stock

Madrigal Pharmaceuticals, Inc. finds support from accumulated volume at $510.68 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $14.43 between high and low, or 2.84%. For the last week, the stock has had daily average volatility of 3.49%.

Our recommended stop-loss: $495.90 (-3.42%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 14 days ago.)

Trading Expectations (MDGL) For The Upcoming Trading Day Of Wednesday 24th

For the upcoming trading day on Wednesday, 24th we expect Madrigal Pharmaceuticals, Inc. to open at $514.33, and during the day (based on 14 day Average True Range), to move between $503.56 and $523.30, which gives a possible trading interval of +/-$19.73 (+/-3.92%) up or down from last closing price. If Madrigal Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 3.92% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $510.68 (0.54%) than the resistance at $518.76 (1.04%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Madrigal Pharmaceuticals, Inc. stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term.

Current score: 2.333 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 24, 2026 - $514.33 ( 0.176%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk